Literature DB >> 1955265

Morbidity due to Schistosoma mansoni among sugar-cane cutters in Zimbabwe.

J Ndamba1, N Makaza, K C Kaondera, M Munjoma.   

Abstract

Quantitative determination of Schistosoma mansoni infection was carried out on 1995 cane cutters of the Hippo Valley and Triangle Sugar Estates. A total of 315 cutters were chosen for the study on the basis of S. mansoni infection and lack of anti-schistosomal chemotherapy during the previous three years. Stool consistency and blood and mucus in stool were determined for all the infected cutters. Overt and occult blood in stool was detected in a significantly high number of infected people compared to the control subjects (chi 2 p less than 0.001). However, the blood loss was found to have no anaemia-producing effect as determined by haemoglobin and red blood cell counts. Watery stool was prevalent among people with egg output exceeding 500 eggs per gram of stool. Mucus in stool was found to be more prevalent among infected people compared to the control subjects but the difference was not significant (p greater than 0.05). Symmer's periportal fibrosis (PPF) of various degrees of severity was detected in 47% of the infected people and grade one liver fibrosis was found in 7.5% of the control subjects (p less than 0.0001). Some 54.5% of those infected complained of abdominal pains compared to 35% of uninfected controls (p less than 0.01). There was a significant difference in the rate of absenteeism from work due to abdominal pains and diarrhoea among the infected and uninfected cane cutters (p less than 0.02).

Entities:  

Mesh:

Year:  1991        PMID: 1955265     DOI: 10.1093/ije/20.3.787

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  6 in total

1.  Intestinal schistosomiasis in mothers and young children in Uganda: investigation of field-applicable markers of bowel morbidity.

Authors:  Martha Betson; Jose Carlos Sousa-Figueiredo; Candia Rowell; Narcis B Kabatereine; J Russell Stothard
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

2.  Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial.

Authors:  Remigio M Olveda; Luz P Acosta; Veronica Tallo; Palmera I Baltazar; Jenny Lind S Lesiguez; Georgette G Estanislao; Edna B Ayaso; Donna Bella S Monterde; Antonio Ida; Nora Watson; Emily A McDonald; Hannah W Wu; Jonathan D Kurtis; Jennifer F Friedman
Journal:  Lancet Infect Dis       Date:  2015-11-02       Impact factor: 25.071

3.  Praziquantel for the treatment of schistosomiasis during human pregnancy.

Authors:  Jennifer F Friedman; Remigio M Olveda; Mark H Mirochnick; Amaya L Bustinduy; Alison M Elliott
Journal:  Bull World Health Organ       Date:  2017-11-27       Impact factor: 9.408

4.  Ultrasound and intestinal lesions in Schistosoma mansoni infection: A case-control pilot study outside endemic areas.

Authors:  Francesca Tamarozzi; Dora Buonfrate; Geraldo Badona Monteiro; Joachim Richter; Federico Giovanni Gobbi; Zeno Bisoffi
Journal:  PLoS One       Date:  2018-12-18       Impact factor: 3.240

5.  Use of fecal occult blood tests as epidemiologic indicators of morbidity associated with intestinal schistosomiasis during preventive chemotherapy in young children.

Authors:  Martha Betson; José Carlos Sousa-Figueiredo; Narcis B Kabatereine; J Russell Stothard
Journal:  Am J Trop Med Hyg       Date:  2012-08-27       Impact factor: 2.345

6.  Fecal occult blood and fecal calprotectin as point-of-care markers of intestinal morbidity in Ugandan children with Schistosoma mansoni infection.

Authors:  Amaya L Bustinduy; José C Sousa-Figueiredo; Moses Adriko; Martha Betson; Alan Fenwick; Narcis Kabatereine; J Russell Stothard
Journal:  PLoS Negl Trop Dis       Date:  2013-11-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.